Abound Financial’s Sanofi SNY Stock Holding History

Abound Financial’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.17K	Hold	168	–	–	﹤0.01%	235
2026 Q1	$8.09K	Hold	168	–	–	﹤0.01%	218
2025 Q4	$8.14K	Buy	+168	New	+$8.33K	﹤0.01%	216
2025 Q2	–	Sell	-168	Closed	-$9.32K	–	228
2025 Q1	$9.32K	Buy	+168	New	+$9.09K	﹤0.01%	204

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Abound Financial's SNY Position: Q2 2026 in Review

Abound Financial held its Sanofi (SNY) position steady in Q2 2026 at 168 shares worth $7.17K. The position accounts for ﹤0.01% of the portfolio, ranked #235.

Abound Financial first reported a position in SNY in Q1 2025 and has held it in 4 quarters since. The position peaked at $9.32K in Q1 2025. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Abound Financial held 168 shares of Sanofi worth $7.17K as of Q2 2026.
Abound Financial left its Sanofi share count unchanged in Q2 2026.
Sanofi made up ﹤0.01% of Abound Financial's portfolio in Q2 2026, its #235 holding.
Abound Financial first reported a position in Sanofi in Q1 2025 and has held it in 4 quarters since.
Abound Financial's Sanofi position peaked at $9.32K in Q1 2025.
715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Abound Financial's 13F filing for Q2 2026, filed 14 Aug 2026.